| P50 | author | Bin Shan | Q42738140 |
| | Erik K Flemington | Q62569596 |
| P2093 | author name string | Joseph A Lasky | |
| | Mark D Sides | |
| | Gregory J Block | |
| | Reid W Chadwick | |
| P2860 | cites work | PML nuclear bodies | Q22065791 |
| | Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation | Q24316905 |
| | Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2 | Q24516975 |
| | Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies | Q24529499 |
| | The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 |
| | Firefly luciferase gene: structure and expression in mammalian cells | Q29616519 |
| | Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies | Q29620390 |
| | Epstein-Barr virus associated modulation of Wnt pathway is not dependent on latent membrane protein-1. | Q33370930 |
| | Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. | Q33551142 |
| | A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics | Q33596988 |
| | Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells | Q34234406 |
| | Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body | Q78257210 |
| | LMP1 structure and signal transduction | Q34415978 |
| | Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways | Q34721581 |
| | Regulation of matrix metalloproteinase gene expression | Q36682744 |
| | PML and PML nuclear bodies: implications in antiviral defence | Q36753891 |
| | Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus | Q36861507 |
| | Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos | Q37021555 |
| | Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. | Q38520593 |
| | Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies | Q39127821 |
| | Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells | Q39537817 |
| | Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression | Q39593467 |
| | The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells. | Q39669856 |
| | A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. | Q39736828 |
| | Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma | Q39816615 |
| | Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes | Q39868970 |
| | Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. | Q39879963 |
| | Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines | Q39916460 |
| | Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML. | Q39950016 |
| | Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway | Q39992451 |
| | Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway | Q40024497 |
| | Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1. | Q40044810 |
| | Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression | Q40256618 |
| | The Epstein-Barr virus oncoprotein LMP1 inhibits the activity of viral or cellular promoters without inducing cytostasis | Q40305675 |
| | Multiple signal transducers and activators of transcription are induced by EBV LMP-1. | Q40551263 |
| | RECK is a target of Epstein–Barr virus latent membrane protein 1 | Q40616852 |
| | Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB. | Q40648620 |
| | HSV-1 IE protein Vmw110 causes redistribution of PML. | Q40793643 |
| | Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth | Q40884755 |
| | Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production | Q40951743 |
| | Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). | Q41044165 |
| | Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA | Q42258547 |
| | CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. | Q42527769 |
| | Disruption of PML-associated nuclear bodies during human cytomegalovirus infection | Q42822986 |
| | Inhibition of transforming growth factor beta signaling and Smad-dependent activation of transcription by the Latent Membrane Protein 1 of Epstein-Barr virus | Q45734171 |
| | Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). | Q45777008 |
| | The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. | Q45778150 |
| | Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis | Q45874715 |
| | Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. | Q48068389 |
| | An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. | Q53541156 |
| | The acute promyelocytic leukaemia-associated PML gene is induced by interferon. | Q54162565 |
| | Establishment of an epitheloid cell line and a fusiform cell line from a patient with nasopharyngeal carcinoma | Q66848173 |
| | Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs | Q73555510 |
| P921 | main subject | membrane protein | Q423042 |
| P304 | page(s) | 461 | |
| P577 | publication date | 2011-10-05 | |
| P1433 | published in | Virology Journal | Q7934868 |
| P1476 | title | Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies | |
| P478 | volume | 8 | |